Abstract
Oxidative stress has been recently considered as a mediator of nerve cell death in several neurodegenerative diseases. We studied the effect of the parkinsonism-inducing toxine 1-methyl-4-phenyl-pyridine (MPP+) on several parameters of cell distress using native and neuronal PC12 cells. Then, since estrogens have been reported to prevent neuronal degeneration caused by oxidative damage, we investigated the ability of 17β-estradiol (E2); two Ginkgo biloba extracts, EGb 761 and Cp 202; as well as two flavonoids, quercetin and kaempferol, to rescue PC12 cells submitted to MPP+-induced oxidative stress. Our results consistently show that both Ginkgo biloba extracts could prevent cell death in native and neuronal PC12 cells, while in neuronal PC12 cells also quercetin and E2 could reverse MPP+ neurotoxic effet. Western blot analysis demonstrated that MPP+ injuries might modulate dopamine transporter (DAT) protein expression but not estrogen receptor β (ERβ) protein expression. EGb 761 and Cp 202 also modulate DAT and ERβ protein expression in neuronal cells. From these studies, we outline the importance of testing estrogen-like plant-derived molecules as potent antioxidants and examine their effect on protein expression.
Similar content being viewed by others
References
Zhang, Y., Dawson, V. L., and Dawson, T. M. (2000). Neurobiol. Dis. 7(4), 240–250.
Schapira, A. H. (1998). Biochim. Biophys. Acta 1366(1–2), 225–233.
Beal, M. F. (1998). Biochim. Biophys. Acta 1366(1–2), 211–223.
Butterfield, D. A. and Kanski, J. (2001). Mech. Ageing Dev. 122(9), 945–962.
Gutteridge, J. M. and Halliwell, B., eds. (1996). In: Neurodegeneration and neuroprotection in Parkinson’s Disease. Academic: London.
Chiba, K., Trevor, A. J., and Castagnoli, N. Jr. (1985). Biochem. Biophys. Res. Commun. 128(3), 1228–1232.
Kang, D., Miyako, K., Kuribayashi, F., et al. (1997). Arch. Biochem. Biophys. 337(1), 75–80.
Cleeter, M. W., Cooper, J. M., and Schapira, A. H. (1992). J. Neurochem. 58(2), 786–789.
Lotharius, J., Dugan, L. L., and O’Malley, K. L. (1999). J. Neurosci. 19(4), 1284–1293.
Nakamura, K., Bindokas, V. P., Marks, J. D., et al. (2000). Mol. Pharmacol. 58(2), 271–278.
Gonzalez-Polo, R. A., Mora, A., Clemente, N., et al. (2001). Brain Res. Bull. 56(2), 119–123.
Przedborski, S., Vila, M., Jackson-Lewis, V. V., and Dawson, T. M. (2000). Trends Pharmacol. Sci. 21(5), 165.
Lephart, E. D., West, T. W., Weber, K. S., et al. (2002). Neurotoxicol. Teratol. 24(1), 5–16.
Mazur, W. (1998). Baillières Clin. Endocrinol. Metab. 12(4), 729–742.
Bingham, S. A., Atkinson, C., Liggins, J., Bluck, L., and Coward, A. (1998). Br. J. Nutr. 79(5), 393–406.
Gelinas, S. and Martinoli, M. G. (2002). J. Neurosci. Res. 70(1), 90–96.
Watanabe, C. M., Wolffram, S., Ader, P., et al. (2001). Proc. Natl. Acad. Sci. USA 98(12), 6577–6580.
Yao, Z., Drieu, K., and Papadopoulos, V. (2001). Brain Res. 889(1–2), 181–190.
Tendi, E. A., Bosetti, F., Dasgupta, S. F., Stella, A. M., Drieu, K., and Rapoport, S. I. (2002). Neurochem. Res. 27(4), 319–323.
Ramassamy, C., Girbe, F., Christen, Y., and Costentin, J. (1993). Free Radic. Res. Commun. 19(5), 341–350.
Bastianetto, S., Ramassamy, C., Poirier, J., and Quirion, R. (1999). Brain Res. Mol. Brain Res. 66(1–2), 35–41.
Marcocci, L., Packer, L., Droy-Lefaix, M. T., Sekaki, A., and Gardes-Albert, M. (1994). Methods Enzymol. 234, 462–475.
Schindowski, K., Leutner, S., Kressmann, S., Eckert, A., and Muller, W. E. (2001). J. Neural. Transm. 108(8–9), 969–978.
Zhou, L. J. and Zhu, X. Z. (2000). J. Pharmacol. Exp. Ther. 293(3), 982–988.
Guidetti, C., Paracchini, S., Lucchini, S., Cambieri, M., and Marzatico, F. (2001). J. Pharm. Pharmacol. 53(3), 387–392.
Pietri, S., Seguin, J. R., d’Arbigny, P., Drieu, K., and Culcasi, M. (1997). Cardiovasc. Drugs Ther. 11(2), 121–131.
Ramassamy, C., Clostre, F., Christen, Y., and Costentin, J. (1990). J. Pharm. Pharmacol. 42(11), 785–789.
Rojas, P., Rojas-Castaneda, J., Vigueras, R. M., and Rojas, C. (2000). Proc. West Pharmacol. Soc. 43, 87–88.
Wu, W. R. and Zhu, X. Z. (1999). Life Sci. 65(2), 157–164.
Kuiper, G. G., Lemmen, J. G., Carlsson, B., et al. (1998). Endocrinology 139(10), 4252–4263.
Moosmann, B. and Behl, C. (1999). Proc. Natl. Acad. Sci. USA 96(16), 8867–8872.
Lee, V., Trojanowski, J. Q., and Schlaepfer, W. W. (1982). Brain Res. 238(1), 169–180.
Kadota, T., Yamaai, T., Saito, Y., et al. (1996). J. Histochem. Cytochem. 44(9), 989–996.
Nilsen, J., Mor, G., and Naftolin, F. (1998). Menopause 5(4), 211–216.
Itano, Y., Kitamura, Y., and Nomura, Y. (1994). Neurochem. Int. 25(5), 419–424.
Fall, C. P. and Bennett, J. P. Jr. (1999). J. Neurosci. Res. 55(5), 620–628.
Behl, C. (2002). Nat. Rev. Neurosci. 3(6), 433–442.
Cyr, M., Calon, F., Morissette, M., Grandbois, M., Di Paolo, T., and Callier, S. (2000). Curr. Pharm. Des. 6(12), 1287–1312.
Giacobini, E. (1998). Exp. Gerontol. 33(7–8), 865–869.
Miller, M. M. and Franklin, K. B. (1999). Exp. Gerontol. 34(5), 587–604.
Callier, S., Morissette, M., Grandbois, M., Pelaprat, D., and Di Paolo, T. (2001). Synapse 41(2), 131–138.
Leranth, C., Roth, R. H., Elsworth, J. D., Naftolin, F., Horvath, T. L., and Redmond, D. E. Jr. (2000). J. Neurosci. 20(23), 8604–8609.
Sawada, H., Ibi, M., Kihara, T., Urushitani, M., Akaike, A., and Shimohama, S. (1998). J. Neurosci. Res. 54(5), 707–719.
Sherwin, B. B. (1997). Neurology 48(5 Suppl. 7), S21-S26.
Luine, V. N., Richards, S. T., Wu, V. Y., and Beck, K. D. (1998). Horm. Behav. 34(2), 149–162.
Seidl, M. M. and Stewart, D. E. (1998). Can. Fam. Physician 44, 1299–1308.
Behl, C., Skutella, T., Lezoualc’h, F., et al. (1997). Mol. Pharmacol. 51(4), 535–541.
Behl, C. and Manthey, D. (2000). J. Neurocytol. 29(5–6), 351–358.
Moosmann, B., Uhr, M., and Behl, C. (1997). FEBS Lett. 413(3), 467–472.
Vedder, H., Anthes, N., Stumm, G., Wurz, C., Behl, C., and Krieg, J. C. (1999). J. Neurochem. 72(6), 2531–2538.
Roth, A., Schaffner, W., and Hertel, C. (1999). J. Neurosci. Res. 57(3), 399–404.
Garcia-Segura, L. M., Azcoitia, I., and DonCarlos, L. L. (2001). Prog. Neurobiol. 63, 29–60.
Ahlemeyer, B., Selke, D., Schaper, C., Klumpp, S., and Krieglestein, J. (2001). Eur. J. Pharmacol. 430, 1–7.
Welshons, W. V., Lieberman, M. E., and Gorski, J. (1984). Nature 307(5953), 747–759.
Bastianetto, S., Ramassamy, C., Christen, Y., Poirier, J., and Quirion, R. (1998). Adv. Gingko Biloba Res. 7, 85–99.
Roehm, N. W., Rodgers, G. H., Hatfield, S. M., and Glasebrook, A. L. (1991). J. Immunol. Methods 142(2), 257–265.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gagné, B., Gélinas, S., Bureau, G. et al. Effects of estradiol, phytoestrogens, and ginkgo biloba extracts against 1-methyl-4-phenyl-pyridine-induced oxidative stress. Endocr 21, 89–95 (2003). https://doi.org/10.1385/ENDO:21:1:89
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:21:1:89